Monoclonal Antibodies

More Treatment Topics

Chemotherapy | Immunotherapy | Radiotherapy | Treatment

According to a new study published in the Proceedings of the National Academy of

The results of a pair of long-term survival studies indicate the therapeutic value of

Bexxar® (tositumomab and iodine I 131 ) is a radiolabled

Rituxan® is the brand marketing name of the monoclonal

Oncolym (131I Lym-1) is an Iodine 131 radiolabled

According to a recent randomized controlled trial, rituximab increased the duration of remission

Biopharmaceutical company MorphoSys is reporting that it has been given fast track

The drug Rituximab is showing to slow symptoms of lymphoma, but does it increase survival:

According to findings to be reported at the annual meeting of the American Society of Clinical

Pharmaceutical giant Pfizer is withdrawing the monoclonal antibody

Today the US Food and Drug Administration granted accelerated approval for Darzalex (

At the 17th Congress of the European Hematology Association (EHA), biopharmaceutical company

TG Therapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has